High pressure liquid chromatographic analysis of in vivo metabolites of N-(substituted phenyl)-N′-(1,3,5-trimethyl pyrazole-4-yl)thioureas in rats

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 32, Issue 4, 2007, Pages 225-232

  Kocyigit Kaymakcioglu, Bedia ^a   Yilmaz, Ufuk ^a   Aricioglu, Feyza ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

HPLC; in vivo metabolism; Pyrazoles; Thioureas

Indexed keywords

N (4 CHLOROPHENYL) N (1,3,5 TRIMETHYL PYRAZOLE 4 YL)THIOUREA; N (4 CHLOROPHENYL) N (3,5 DIMETHYL PYRAZOLE 4 YL)THIOUREA; N (4 FLUOROPHENYL) N (1,3,5 TRIMETHYL PYRAZOLE 4 YL)THIOUREA; N (4 FLUOROPHENYL) N (3,5 DIMETHYL PYRAZOLE 4 YL)THIOUREA; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MALE; NONHUMAN; RAT;

EID: 39449126888     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03191008     Document Type: Article

References (20)

1. Rollas S., Koçyiǧit-Kaymakçioǧlu B. (2003): Biological activity of disubstituted thiourea derivatives. Curr. Top. Med. Chem., 3: 121-134.
2. Küçükgüzel İ., Küçükgü zel S.G., Rollas S., Kiraz M. (2001): Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials. Bioorg. Med. Chem. Lett., 11: 1703-1707.
3. Sriram D., Yogeeswari P., Madhu K. (2006): Synthesis and in vitro antitubercular activity of some 1-[(4-substituted) phenyl]-3-(4-{1-[(pyridine-4- carbonyl)hydrazono] ethyl} phenyl) thioureas. Bioorg. Med. Chem. Lett., 16: 876-878.
4. Campo R.D., Criado J.J., Gheorghe R., Gonzales F.J., Hermosa M.R., Sanz F., Manzano J.L., Monte E., Fernandez E.R. (2004): N-benzoyl- N′-alkylthioureas and their complexes with Ni(II), Co(III) and Pt(II) - crystal structure of 3-benzoyl-1 -butyl-1-methyl-thiourea: activity against fungi and yeast. J. Inorg. Biochem., 98: 1307-1314.
5. Rollas S., Büyüktimkin S., Çevikbaş A. (1991): N-[4-(3H-1,3,4-oxadiazoline-2-thione-5-yl)phenyl]-/N′- substituted thioureas synthesis and antimicrobiological activities. Arch. Pharm. (Weinheim), 324: 189-190.
6. Karakus S., Rollas S. (2002): Synthesis and antituberculosis activity of new N-phenyl-N′-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2- yl)phenyl]thioureas. Farmaco, 57: 577-581.
7. Grandi M.J.D., Curan K.J., Feigelson G., Prashad A., Ross A.A., Visalli R., Fairhurst J., Feld B., Bloom J.D. (2004): Thiourea inhibitors of herpes viruses. Part 3: Inhibitors of Varicella zoster virus. Bioorg. Med. Chem. Lett., 14: 4157-4160.
8. Venkatachalam T.K., Sudbeck E.A., Uckun F.M. (2001): Regiospecific synthesis, X-ray crystal structure and biological activities of 5-bromothiophenethyl thioureas. Tetrahedron Lett., 42: 6629-6632.
9. Vig R., Mao C., Venkatachalam T.K., Ahlgren L.T., Sudbeck E.A., Uckun F.M. (1998): Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg. Med. Chem. Lett., 6: 1789-1797.
10. Högberg M., Engelhardt P., Vrang L., Zhang H. (2000): Bioisosteric modification of PETT-HIV-1 RT-inhibitors: Synthesis and biological evaluation. Bioorg. Med. Chem. Lett., 10: 265-268
11. Venkatachalam T.K., Qazi S., Samuel P., Uckun F.M. (2003): Substituted heterocyclic thiourea compounds as a new class of anti-allergic agents Inhibiting IgE/FcεRI receptor mediated mast cell leukotriene release. Bioorg. Med. Chem. Lett., 11: 1095-1105.
12. Dimmorck J.R., Vashista S.C., Stables J.P. (2000): Ureylene anticonvulsants and related compounds. Pharmazie, 55: 490-494.
13. Kaymakçioǧlu B.K., Rollas S., Körceǧez E., Aricioǧlu F. (2005): Synthesis and biological evaluation of new N-substituted-N′-(3,5-di/1,3,5-trimethylpyrazole-4-yl) thiourea/urea derivatives. Eur. J. Pharm. Seci., 26: 97-103.
14. Debruyne D., Moulin M.A., Bricard H., Bigot M.C. (1985): Liquid chromatographic determination of noxytiolin and 1-methyl-2-thiourea in serum: application to pharmacokinetic studies in rabbits and humans. J. Pharm. Sci., 74: 224-226.
15. Jones A.R., Mashford P.M. (1983): The fate of N-methyl-N′- (hydroxymethyl)thiourea in the rat. Xenobiotica, 13: 73-79.
16. Yegba A., Menager S., Verite P., Farnoux C.C., Lafont O. (1995): Competition between two metabolic pathways: oxidation and desulfuration in the thiobarbiturate series. Lab. Pharm. Biopharm., 11: 1295-1296.
17. Stevens G.J., Hitchcock K., Wang Y.K., Coppala G.M., Versace R.W., Chin J.A., Shapiro M., Suwanrumpha S., Mangold, B.L.K. (1997): In vitro metabolism of N-(5-chloro-2-methylphenyl)-N′-(2-methylpropyl)thiourea: species comparison and identification of a novel thiocarbamide-glutathione adduct. Chem. Res.Toxicol., 10: 733-741.
18. Lee J., La S., Ahn B.R., Jeong T.C., Kim D.H. (2004): Metabolism of 1-{3-[3-(4-cyanobenzyl)-3H-imidazol-4-yl]-propyl}-3-(6-methoxypyridin-3- yl)-1-(2-trifluoromethyl-benzyl)thiourea (YH3945), a novel anticancer drug, in rats using the C-14-labeled compound. Rapid Comm. M. Spec, 18: 1901-1910.
19. Kaymakçi̇oǧlu B.K., Rollas S., Ancioǧlu F. (2003): İn vivo metabolism of N-phenyl-N′-(3,5- dimethylpyrazole-4-yl) thiourea in rats. Eur. J. Drug Metab. Pharmacokinet., 28(4):273-278.
20. Kaymakçioglu B.K., Oruc E.E., Unsalan S., Kabasakal L., Rollas, S. (2006): High-pressure liquid chromatographic analysis for identification of in vitro and in vivo metabolites of 4-phenethyl-5-[4-(1-(2-hydroxyethyl)-3,5- dimethyl-4-pyrazolylazo)phenyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 831(1-2): 184-189.